🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Studying samples of tissue from patients with cancer in the labo...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2006-11
Trial ID
NCT00897663
RATIONALE: Measuring blood levels of tumor cells in patients with breast ca...
Status
Completed
Location
Institut Curie Hopital
Start Date
2007-05
Trial ID
NCT00898014
Treatments Being Tested
The presence of malignant cells in lymph nodes is a critical parameter in t...
Status
Terminated
Location
UPMC Hillman Cancer Center
Start Date
2009-09
Trial ID
NCT00871533
Treatments Being Tested
RATIONALE: Antiviral drugs, such as nelfinavir mesylate, may help prevent c...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2006-03
Trial ID
NCT00233948
This phase Ib/II trial studies the best dose of glembatumumab vedotin when ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-04-20
Trial ID
NCT03326258
Treatments Being Tested
RATIONALE: Studying samples of tissue and blood in the laboratory from pati...
Status
Completed
Location
Vanderbilt-Ingram Cancer Center
Start Date
2006-02
Trial ID
NCT00483457
RATIONALE: Alemtuzumab and glucocorticoids, such as prednisone or methylpre...
Status
Completed
Location
Fred Hutchinson Cancer Research Center
Start Date
2006-07
Trial ID
NCT00410657
RATIONALE: Bortezomib may stop the growth of cancer cells by blocking some ...
Status
Completed
Location
City of Hope Medical Center
Start Date
2011-10-03
Trial ID
NCT01267812
Septic shock is associated with acquired immunoparalysis which is associate...
Status
Completed
Location
Hôpital St Eloi
Start Date
2014-06
Trial ID
NCT03136081
Treatments Being Tested
RATIONALE: Deferasirox may remove excess iron from the body caused by blood...
Status
Completed
Location
Comprehensive Cancer Center of Wake Forest University
Start Date
2011-01
Trial ID
NCT01273766
Treatments Being Tested